1100617-38-6 Usage
Description
(3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4,5-dihydro-2-benzoxepin-1(3H)-one is a complex organic compound characterized by its pale yellow foam appearance. It is an impurity that can be formed during the synthesis of Montelukast, a medication used for treating asthma and allergic rhinitis.
Uses
As an impurity in Pharmaceutical Production:
(3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4,5-dihydro-2-benzoxepin-1(3H)-one is used as a reference compound in the pharmaceutical industry for quality control and process optimization during the manufacturing of Montelukast. Its presence can indicate the efficiency of the synthesis process and the need for purification steps to ensure the purity and safety of the final drug product.
In Research and Development:
(3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4,5-dihydro-2-benzoxepin-1(3H)-one may also be utilized in research settings to study the side reactions and mechanisms involved in the synthesis of Montelukast and related drugs. Understanding the formation and properties of this impurity can contribute to the development of more efficient synthetic routes and improved drug formulations.
Check Digit Verification of cas no
The CAS Registry Mumber 1100617-38-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,0,6,1 and 7 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1100617-38:
(9*1)+(8*1)+(7*0)+(6*0)+(5*6)+(4*1)+(3*7)+(2*3)+(1*8)=86
86 % 10 = 6
So 1100617-38-6 is a valid CAS Registry Number.
1100617-38-6Relevant articles and documents
Process and intermediate for the production of an intermediate in the production of montelukast
-
Page/Page column 4, (2009/01/24)
The tertiary alcohol α-[3-[(1E)2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-2-(1-hydroxy-1-methylethyl)benzenepropanol, the (αS)-enantioner of which is an intermediate in the production of montelukast, is produced by reacting the novel lactone of formula with
